---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-25-000111"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2025-10-28T23:59:59+00:00"
generated_at: "2026-05-17T01:54:47.593141+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q3 revenue $61.2M (+12% YoY); adjusted EBITDA up 56% to $6.2M; raises FY2025 revenue guidance

## Summary
- Revenue $61.2M, +12% YoY (17% ex-7D capital); Trauma & Deformity +17%, Scoliosis +4%.
- GAAP EPS -$0.50 vs -$0.34; non-GAAP EPS -$0.24 vs -$0.18; net loss $11.8M vs $7.9M.
- Adjusted EBITDA $6.2M (+56% YoY); free cash flow usage improved to $3.4M from $11.6M.
- FY2025 revenue guidance raised to $233.5-234.5M (+14-15%); adjusted EBITDA guidance reiterated $15-17M.
- Recorded $2.3M restructuring charge and $2.3M intangible impairment (ApiFix, Telos, Medtech).

## SEC filing metadata
- accession: 0001425450-25-000111
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2025-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/0001425450-25-000111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000111/kids-20251028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-25-000111
- JSON: https://secwatch.observer/filing/0001425450-25-000111.json
- Plain text: https://secwatch.observer/filing/0001425450-25-000111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.